中国免疫学杂志
中國免疫學雜誌
중국면역학잡지
CHINESE JOURNAL OF IMMUNOLOGY
2014年
5期
582-586
,共5页
楚鹰%王亭亭%芮昱文%宋思维%苏艾荣%程林%宋红勇%郑大同%吴稚伟
楚鷹%王亭亭%芮昱文%宋思維%囌艾榮%程林%宋紅勇%鄭大同%吳稚偉
초응%왕정정%예욱문%송사유%소애영%정림%송홍용%정대동%오치위
人免疫缺陷病毒1型%gp120可变区1/2%鼠胸腺基质淋巴细胞生成素%293 F表达体系%融合蛋白
人免疫缺陷病毒1型%gp120可變區1/2%鼠胸腺基質淋巴細胞生成素%293 F錶達體繫%融閤蛋白
인면역결함병독1형%gp120가변구1/2%서흉선기질림파세포생성소%293 F표체체계%융합단백
HIV-1%gp120 V1/V2%TSLP%293F expression system%Fusion protein
目的:将鼠胸腺基质淋巴细胞生成素( mouse thymic stromal lymphopoietin ,mTSLP)与人免疫缺陷病毒1型( hu-man immunodeficiency virus type 1,HIV-1)B亚型分离株BAL的gp120 V1/V2结构域在293F真核细胞表达体系中进行融合表达。方法:以真核表达质粒pCEP-Pu为载体,构建mTSLP与gp120BAL V1V2融合基因的重组蛋白表达质粒pCTV1V2BAL。限制性酶切电泳与测序验证质粒构建正确后,使用PEI瞬时转染293 F悬浮细胞,表达产物以SDS-PAGE与Western blot进行分析,并对纯化后重组蛋白的V1/V2抗原表位进行了ELISA分析。结果:SDS-PAGE、Western blot分析显示,在表观分子量35 kD至55 kD的范围内存在一条不均一的糖蛋白条带,并且能与抗mTSLP多克隆抗体和抗His标签单克隆抗体发生反应。 HIV-1阳性病人血清能够识别mTSLP-V1/V2BAL上的HIV-1V1/V2抗原表位。结论:在293F中成功表达了mTSLP-V1/V2BAL融合蛋白,该蛋白具有HIV-1gp120BALV1/V2区的抗原表位,能够用于HIV-1 gp120 V1/V2亚单位疫苗的研究。
目的:將鼠胸腺基質淋巴細胞生成素( mouse thymic stromal lymphopoietin ,mTSLP)與人免疫缺陷病毒1型( hu-man immunodeficiency virus type 1,HIV-1)B亞型分離株BAL的gp120 V1/V2結構域在293F真覈細胞錶達體繫中進行融閤錶達。方法:以真覈錶達質粒pCEP-Pu為載體,構建mTSLP與gp120BAL V1V2融閤基因的重組蛋白錶達質粒pCTV1V2BAL。限製性酶切電泳與測序驗證質粒構建正確後,使用PEI瞬時轉染293 F懸浮細胞,錶達產物以SDS-PAGE與Western blot進行分析,併對純化後重組蛋白的V1/V2抗原錶位進行瞭ELISA分析。結果:SDS-PAGE、Western blot分析顯示,在錶觀分子量35 kD至55 kD的範圍內存在一條不均一的糖蛋白條帶,併且能與抗mTSLP多剋隆抗體和抗His標籤單剋隆抗體髮生反應。 HIV-1暘性病人血清能夠識彆mTSLP-V1/V2BAL上的HIV-1V1/V2抗原錶位。結論:在293F中成功錶達瞭mTSLP-V1/V2BAL融閤蛋白,該蛋白具有HIV-1gp120BALV1/V2區的抗原錶位,能夠用于HIV-1 gp120 V1/V2亞單位疫苗的研究。
목적:장서흉선기질림파세포생성소( mouse thymic stromal lymphopoietin ,mTSLP)여인면역결함병독1형( hu-man immunodeficiency virus type 1,HIV-1)B아형분리주BAL적gp120 V1/V2결구역재293F진핵세포표체체계중진행융합표체。방법:이진핵표체질립pCEP-Pu위재체,구건mTSLP여gp120BAL V1V2융합기인적중조단백표체질립pCTV1V2BAL。한제성매절전영여측서험증질립구건정학후,사용PEI순시전염293 F현부세포,표체산물이SDS-PAGE여Western blot진행분석,병대순화후중조단백적V1/V2항원표위진행료ELISA분석。결과:SDS-PAGE、Western blot분석현시,재표관분자량35 kD지55 kD적범위내존재일조불균일적당단백조대,병차능여항mTSLP다극륭항체화항His표첨단극륭항체발생반응。 HIV-1양성병인혈청능구식별mTSLP-V1/V2BAL상적HIV-1V1/V2항원표위。결론:재293F중성공표체료mTSLP-V1/V2BAL융합단백,해단백구유HIV-1gp120BALV1/V2구적항원표위,능구용우HIV-1 gp120 V1/V2아단위역묘적연구。
Objective:To express fusion protein of mouse thymic stromal lymphopoietin (TSLP) and HIV-1 gp120BAL V1/V2 subdomain in 293F cell.Methods:Full length of the V1V2 sequence from BAL isolate was fused with the C-terminus of mouse thymic stromal lymphopoietin (TSLP) and sub-cloned into pCEP-Pu vector to construct the eukaryotic expression plasmid-pCTV1V2BAL.The recombinant plasmid was confirmed by enzyme digestion and sequencing , then transfected into 293 F cells using PEI as a transfection reagent .The fusion protein was purified by metal chelate affinity chromatography and characterized by SDS -PAGE and Western blot . The epitopes of V1/V2 in fusion protein were identified by ELISA .Results:The SDS-PAGE and Western blot results showed that there were highly heterogeneous glycoprotein bands at the site between 35 kD and 55 kD, which reacted with anti-mTSLP rabbit polyclonal antibody and anti-His tag mouse monoclonal antibody .The ELISA analysis showed that antibodies to V 1/V2BAL existed in the sera of HIV-1 positive patients.Conclusion:The mTSLP-V1/V2 fusion protein was successfully expressed in 293F cells, which may be useful for HIV-1 vaccine research .